Plexus Corp.
PLXS
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
12.6% downsideOvervalued by 12.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.03 Billion |
|---|---|
| Enterprise Value | $8.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $6.39 |
| Beta | 0.9 |
| Outstanding Shares | 26,762,000 |
Return
| Return on Equity | 12.59% |
|---|---|
| Return on Assets | 5.58% |
| Return on Invested Capital | 13.43% |
Valuation & Multiples
| P/E Ratio | 42.81 |
|---|---|
| PEG | 155.79 |
| Price to Sales | 1.89 |
| Price to Book Ratio | 5.52 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | 38.6 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0234▼ 2.85% |
|---|---|
| Total Calls | 93,900▼ 0.42% |
| Total Puts | 2,200▼ 55.10% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 100.31%▲ 0.92% |
|---|---|
| Total Invested | $5.40B▲ 38.10% |
| Investors Holding | 385▲ 45.00% |
ESG Score
No data
About Plexus Corp.
CEO: Todd Kelsey Relevant Senate Committees
Controls tax policy and trade tariffs. Plexus's margins are highly sensitive to tariffs on imported components and corporate tax incentives for R&D and manufacturing.
Determines specific cash allocations for defense and healthcare programs, directly impacting the revenue streams of Plexus's core customer segments.
Regulates the FDA. Since a large portion of Plexus's revenue comes from Healthcare and Life Sciences, FDA regulatory shifts are vital to their operations.
Plexus is a key manufacturer for the Aerospace and Defense sector. The NDAA determines the funding levels for programs that directly drive Plexus's order book.
Oversees the FCC and FAA. Plexus serves the communications and aerospace sectors, meaning regulatory changes in these industries directly impact their customer demand and product compliance.